Validation Data on More Than 100 Patients published in Journal of Molecular Diagnostics CHICAGO, April 25, 2025 /PRNewswire/ -- Belay Diagnostics, a CLIA/CAP accredited laboratory focused on the ...

Neurofilament light chains in the serum and cerebrospinal fluid show strong potential for monitoring neurodegenerative and ...

For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI scans may reveal a suspicious-looking lesion, but the only sure way to ...

As the world’s population ages, health experts are bracing for higher rates of age-related diseases, including Alzheimer’s. Finding new ways to diagnose the condition is more of a priority than ever, ...

A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and the Johns Hopkins Department of Neurosurgery can accurately identify brain cancers ...

In a recent study published in JAMA Neurology, an international team of researchers evaluated whether plasma phosphorylated tau 217 (p-tau217) could classify amyloid β (Aβ) status in cognitively ...

In May, the FDA cleared the first blood-based diagnostic test for Alzheimer's disease, the Lumipulse G pTau 217/β-Amyloid ...

CHICAGO, April 25, 2025 /PRNewswire/ -- Belay Diagnostics, a CLIA/CAP accredited laboratory focused on the development and commercialization of molecular diagnostics targeting central nervous system ...